Andrew D. Goldberg - Dec 15, 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Dec 15, 2023
Transactions value $
$18,960
Form type
4
Date filed
12/19/2023, 06:30 PM
Previous filing
Jun 26, 2023
Next filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Purchase $19K +1K +50% $18.96 3K Dec 15, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.